(Alliance News) - Stock prices in London were lower at midday on Monday, as investors wait for a number of inflationary prints later in the week. Read More
(Alliance News) - Stock prices in London opened just about higher on Monday morning, inching up despite disappointing data from China, and reports of new restrictions on the UK gambling sector. Read More
(Alliance News) - London's FTSE 100 moved higher on Wednesday morning, shaking off nervy trade in China, where stimulus disappointment weighed on the mood. Read More
(Alliance News) - AstraZeneca PLC on Monday entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd to advance the development of an early stage, novel small molecule lipoprotein disruptor for patients with dyslipidaemia. Read More
(Alliance News) - AstraZeneca PLC on Monday said an independent data monitoring committee recommended an early trial stop for its medication Airsupra due to overwhelming efficacy at pre-planned analysis for the treatment of asthma. Read More
(Alliance News) - AstraZeneca PLC on Thursday said its cancer treatment Calquence obtained priority review by the US Food & Drug Administration for a form of lymphoma. Read More
(Alliance News) - Stock prices in London were predominantly lower at midday on Wednesday, though the FTSE 100 continued in the green, thanks to its exposure to the oil and defence sectors. Read More
(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their cancer drug Enhertu received a priority review by the Food & Drug Administration in the US for some forms of breast cancer. Read More
(Alliance News) - Stock prices in London opened a mixed bag in London on Tuesday, with the FTSE 100 in the green, but compatriot indices in the red, ahead of a slew of manufacturing PMIs later in the day. Read More
(Alliance News) - Stocks opened higher in London on Tuesday morning, after data showed that UK shop prices have moved further into deflation. Read More
(Alliance News) - Stock prices in London were still in the green at midday on Thursday, during a week in which China has been "the talk of the town". Read More
(Alliance News) - AstraZeneca PLC on Thursday said that its cancer drug Tagrisso has been approved in the US for certain type of lung cancer. Read More
(Alliance News) - A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the UK's Court of Appeal. Read More
(Alliance News) - AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow this month to hopes for the product. Read More
(Alliance News) - Stocks in London are to open higher on Monday, ahead of flash composite purchasing managers' index data from the US, the UK and mainland Europe. Read More
(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US. Read More
(Alliance News) - Stock prices in London went into Wednesday's afternoon on weaker footing, with trade tepid ahead of the evening's Federal Reserve decision, which is on a knife-edge. Read More
